Emilio Alba Conejo

Title: Emilio Alba Conejo: Innovator in Oncology

Introduction

Emilio Alba Conejo is a notable inventor based in Málaga, Spain. He has made significant contributions to the field of oncology, particularly in the area of breast cancer treatment. His innovative work focuses on predicting the risk of tumor recurrence, which is crucial for patient management and treatment strategies.

Latest Patents

Emilio Alba Conejo holds a patent titled "Microrna signature as an indicator of the risk of early recurrence in patients with breast cancer." This invention relates to methods for predicting the risk of recurrence of breast tumors by measuring the expression levels of specific microRNAs. The patent outlines a method that involves assessing the expression levels of at least one miRNA from a defined group, which includes miR-149-5p, miR-10a-5p, miR-20b-5p, miR-30a-3p, and miR-342-5p. A change in the expression level of these miRNAs in tumor samples compared to control samples indicates a high risk of tumor recurrence. The invention also includes tools and kits designed to facilitate this method.

Career Highlights

Throughout his career, Emilio has worked with prominent organizations such as Servicio Andaluz de Salud and Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS). His work in these institutions has allowed him to advance his research and contribute to the field of biomedical science.

Collaborations

Emilio has collaborated with esteemed colleagues, including José Lozano Castro and Luis Gustavo Pérez Rivas. These partnerships have enriched his research and fostered innovation in cancer treatment methodologies.

Conclusion

Emilio Alba Conejo's contributions to oncology through his innovative patent demonstrate his commitment to improving patient outcomes in breast cancer treatment. His work exemplifies the importance of research and innovation in the medical field.